Eye Diseases: From Pathophysiology to Novel Therapeutic Approaches
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 30
Special Issue Editor
Interests: cataracts; corneal pathology and treatment; eye traumatology; neuroprotection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The progress made in clinical and experimental ophthalmology in recent years is remarkable. It would not be possible without developments in our progressively better understanding of the pathophysiology of eye diseases. New medicines and therapeutic strategies which have been introduced and implemented into everyday clinical practice are consequences of the work of laboratory experiments and observations on genetic, biochemical, proteomic, cellular, and physiological levels. In this Special Issue, entitled "Eye Diseases: From Pathophysiology to Novel Therapeutic Approaches", we welcome authors to submit papers that highlight new achievements in these fields. We encourage submissions focused on the molecular mechanisms underlying eye diseases and innovative therapeutic approaches, rooted in molecular research. We hope that improving our knowledge and outlining the most recent achievements in molecular insights brings new therapeutic possibilities to help rescue vision and inspires our readers and scientists by the new discoveries in both experimental and clinical ophthalmology.
Dr. Tomasz Chorągiewicz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- eye diseases
- genetic
- biochemical
- proteomic
- cellular and physiological level
- innovative therapeutic approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
